Charles Schwab’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-797,299
| Closed | -$2.42M | – | 3533 |
|
|
2024
Q4 | $2.42M | Buy |
797,299
+6,462
| +0.8% | +$28.1K | ﹤0.01% | 2617 |
|
|
2024
Q3 | $4.1M | Buy |
790,837
+41,250
| +6% | +$205K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $1.93M | Buy |
749,587
+49,537
| +7% | +$169K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $3.44M | Buy |
700,050
+22,686
| +3% | +$134K | ﹤0.01% | 2425 |
|
|
2023
Q4 | $5.95M | Buy |
677,364
+13,826
| +2% | +$113K | ﹤0.01% | 2231 |
|
|
2023
Q3 | $7.61M | Buy |
663,538
+36,493
| +6% | +$702K | ﹤0.01% | 2060 |
|
|
2023
Q2 | $15.9M | Buy |
627,045
+19,710
| +3% | +$614K | ﹤0.01% | 1654 |
|
|
2023
Q1 | $19.6M | Buy |
607,335
+717
| +0.1% | +$22.4K | 0.01% | 1493 |
|
|
2022
Q4 | $11.2M | Buy |
606,618
+38,059
| +7% | +$871K | ﹤0.01% | 1802 |
|
|
2022
Q3 | $15.4M | Buy |
568,559
+86,844
| +18% | +$1.76M | 0.01% | 1570 |
|
|
2022
Q2 | $6.66M | Sell |
481,715
-9,747
| -2% | -$150K | ﹤0.01% | 2052 |
|
|
2022
Q1 | $9.58M | Buy |
491,462
+14,638
| +3% | +$222K | ﹤0.01% | 1982 |
|
|
2021
Q4 | $7.78M | Buy |
476,824
+5,557
| +1% | +$92.6K | ﹤0.01% | 2133 |
|
|
2021
Q3 | $13.1M | Buy |
471,267
+3,056
| +0.7% | +$87.2K | ﹤0.01% | 1852 |
|
|
2021
Q2 | $13.9M | Buy |
468,211
+21,270
| +5% | +$614K | ﹤0.01% | 1821 |
|
|
2021
Q1 | $12.5M | Buy |
446,941
+35,910
| +9% | +$993K | ﹤0.01% | 1828 |
|
|
2020
Q4 | $11.6M | Buy |
411,031
+5,169
| +1% | +$134K | ﹤0.01% | 1774 |
|
|
2020
Q3 | $10.2M | Buy |
405,862
+69,842
| +21% | +$1.83M | ﹤0.01% | 1682 |
|
|
2020
Q2 | $8.21M | Buy |
336,020
+30,846
| +10% | +$609K | ﹤0.01% | 1765 |
|
|
2020
Q1 | $4.52M | Buy |
305,174
+35,815
| +13% | +$741K | ﹤0.01% | 1886 |
|
|
2019
Q4 | $4.37M | Buy |
269,359
+24,274
| +10% | +$376K | ﹤0.01% | 2089 |
|
|
2019
Q3 | $3.19M | Buy |
245,085
+2,321
| +1% | +$28.4K | ﹤0.01% | 2197 |
|
|
2019
Q2 | $3.15M | Buy |
242,764
+17,383
| +8% | +$219K | ﹤0.01% | 2184 |
|
|
2019
Q1 | $3.55M | Buy |
225,381
+48,353
| +27% | +$838K | ﹤0.01% | 2141 |
|
|
2018
Q4 | $3.56M | Sell |
177,028
-898
| -0.5% | -$19.8K | ﹤0.01% | 2081 |
|
|
2018
Q3 | $4.42M | Buy |
177,926
+25,131
| +16% | +$683K | ﹤0.01% | 2110 |
|
|
2018
Q2 | $4.2M | Buy |
152,795
+18,179
| +14% | +$546K | ﹤0.01% | 2090 |
|
|
2018
Q1 | $4.15M | Buy |
134,616
+16,307
| +14% | +$525K | ﹤0.01% | 2039 |
|
|
2017
Q4 | $4.23M | Buy |
118,309
+1,051
| +0.9% | +$30.2K | ﹤0.01% | 2009 |
|
|
2017
Q3 | $3.23M | Buy |
117,258
+5,501
| +5% | +$133K | ﹤0.01% | 2091 |
|
|
2017
Q2 | $2.95M | Buy |
111,757
+19,267
| +21% | +$430K | ﹤0.01% | 2083 |
|
|
2017
Q1 | $1.92M | Buy |
92,490
+3,933
| +4% | +$80.8K | ﹤0.01% | 2214 |
|
|
2016
Q4 | $1.83M | Buy |
88,557
+28,842
| +48% | +$483K | ﹤0.01% | 2214 |
|
|
2016
Q3 | $968K | Sell |
59,715
-6,548
| -10% | -$95.1K | ﹤0.01% | 2419 |
|
|
2016
Q2 | $902K | Buy |
66,263
+1,320
| +2% | +$23.3K | ﹤0.01% | 2386 |
|
|
2016
Q1 | $1.13M | Buy |
64,943
+1,476
| +2% | +$30K | ﹤0.01% | 2291 |
|
|
2015
Q4 | $2.17M | Buy |
63,467
+16,625
| +35% | +$576K | ﹤0.01% | 2033 |
|
|
2015
Q3 | $1.4M | Buy |
46,842
+10,608
| +29% | +$322K | ﹤0.01% | 2250 |
|
|
2015
Q2 | $1.16M | Buy |
36,234
+9,561
| +36% | +$246K | ﹤0.01% | 2357 |
|
|
2015
Q1 | $553K | Buy |
26,673
+1,508
| +6% | +$26.1K | ﹤0.01% | 2596 |
|
|
2014
Q4 | $427K | Buy |
25,165
+5,918
| +31% | +$103K | ﹤0.01% | 2684 |
|
|
2014
Q3 | $373K | Buy |
19,247
+3,819
| +25% | +$99.5K | ﹤0.01% | 2698 |
|
|
2014
Q2 | $525K | Buy |
+15,428
| New | +$483K | ﹤0.01% | 2606 |
|
